
Bharti Airtel, which provides telecommunications services, is teaming up with Qualcomm, a chipmaker and wireless tech company, to accelerate the pace of the 5G rollout in India. The companies stated the partnership’s activities would “create new opportunities for small and medium-sized businesses to become viable players in the deployment of 5G networks.”
In a press release, the companies stated their 5G services “will be able to deliver multi-gigabit internet speeds wirelessly to customers and open up a wide range of innovations.” Customers will be able to have “gigabit-size file downloads in seconds and 4K video streaming … across smartphones and computing devices,” as well as smart homes and connected devices.
“Our networks are fully ready for 5G,” said Randeep Sekhon, Bharti Airtel’s chief technology officer. He said the two companies’ technologies “will be well placed to usher India into the next era of hyper-fast … digital connectivity.” Bharti Airtel is headquartered in New Delhi.
“This collaboration is expected to play a critical role in Airtel’s plans to add 5G network coverage and capacity where and when it is needed the most,” said Rajen Vagadia, president of Qualcomm India.
India has increasingly been a focus for Qualcomm, which is headquartered in San Diego. Last July, Qualcomm’s investment arm agreed to put up to US$97 million into Jio Platforms, an Indian telecom company.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas